What is a stock summary page? Click here for an overview.
Business Description
Lifecore Biomedical Inc
NAICS : 325412
SIC : 2833
ISIN : US5147661046
Compare
Compare
Traded in other countries / regions
LFCR.USALDE.Germany Index Membership
Russell 2000Russell 3000Russell 3000Russell 2000 IPO Date
1996-02-15Description
Lifecore Biomedical Inc is a fully integrated contract development and manufacturing organization (CDMO) that offers differentiated capabilities in the development, filling, and finishing of complex sterile injectable pharmaceutical products in syringes and vials. It manufactures injectable-grade Hyaluronic Acid. Lifecore recognizes revenue in two different product categories, CDMO and fermentation.
Financial Strength
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.07 | |||||
| Equity-to-Asset | 0.06 | |||||
| Debt-to-Equity | 8.5 | |||||
| Debt-to-EBITDA | 8.79 | |||||
| Piotroski F-Score | 7/9 | |||||
| Altman Z-Score | 0.37 | |||||
| Beneish M-Score | -3.18 | |||||
| WACC vs ROIC | ||||||
Growth Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 0.5 | |||||
| 3-Year EPS without NRI Growth Rate | -22.8 | |||||
| 3-Year FCF Growth Rate | -18.3 | |||||
| 3-Year Book Growth Rate | -62.3 | |||||
| Future 3-5Y EPS without NRI Growth Rate Estimate | 20.65 | |||||
| Future 3-5Y Total Revenue Growth Rate Estimate | 6.33 |
Momentum Rank
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 70.03 | |||||
| 9-Day RSI | 68.68 | |||||
| 14-Day RSI | 63.09 | |||||
| 3-1 Month Momentum % | -26.32 | |||||
| 6-1 Month Momentum % | 12.22 | |||||
| 12-1 Month Momentum % | 7.9 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 2.32 | |||||
| Quick Ratio | 1.21 | |||||
| Cash Ratio | 0.27 | |||||
| Days Inventory | 172.99 | |||||
| Days Sales Outstanding | 79.83 | |||||
| Days Payable | 71.97 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -1.4 | |||||
| Shareholder Yield % | -4.75 |
Profitability Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 34.88 | |||||
| Operating Margin % | -7.87 | |||||
| Net Margin % | -10.89 | |||||
| FCF Margin % | -11 | |||||
| ROE % | -169.94 | |||||
| ROA % | -5.71 | |||||
| ROIC % | -4.79 | |||||
| 3-Year ROIIC % | 4.05 | |||||
| ROC (Joel Greenblatt) % | 3.2 | |||||
| ROCE % | 2.83 | |||||
| Years of Profitability over Past 10-Year | 5 |
GF Value Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 1.75 | |||||
| PB Ratio | 15.5 | |||||
| EV-to-EBIT | 61.16 | |||||
| EV-to-EBITDA | 24.5 | |||||
| EV-to-Forward-EBITDA | 15.08 | |||||
| EV-to-Revenue | 2.8 | |||||
| EV-to-Forward-Revenue | 2.57 | |||||
| EV-to-FCF | -25.44 | |||||
| Price-to-GF-Value | 0.87 | |||||
| Price-to-Median-PS-Value | 2.09 | |||||
| Earnings Yield (Greenblatt) % | 1.64 | |||||
| FCF Yield % | -5.97 | |||||
| Forward Rate of Return (Yacktman) % | 22.47 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NAS:LFCR
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Lifecore Biomedical Inc Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 130.859 | ||
| EPS (TTM) ($) | -0.59 | ||
| Beta | 0.56 | ||
| 3-Year Sharpe Ratio | 0.01 | ||
| 3-Year Sortino Ratio | 0.02 | ||
| Volatility % | 75.36 | ||
| 14-Day RSI | 63.09 | ||
| 14-Day ATR ($) | 0.286353 | ||
| 20-Day SMA ($) | 6.2235 | ||
| 12-1 Month Momentum % | 7.9 | ||
| 52-Week Range ($) | 3.6793 - 7.99 | ||
| Shares Outstanding (Mil) | 37.03 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 7 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Lifecore Biomedical Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Lifecore Biomedical Inc Stock Events
| Event | Date | Price ($) | ||
|---|---|---|---|---|
| No Event Data | ||||
Lifecore Biomedical Inc Frequently Asked Questions
What is Lifecore Biomedical Inc(LFCR)'s stock price today?
The current price of LFCR is $6.51. The 52 week high of LFCR is $7.99 and 52 week low is $3.68.
When is next earnings date of Lifecore Biomedical Inc(LFCR)?
The next earnings date of Lifecore Biomedical Inc(LFCR) is 2025-04-08 Est..
Does Lifecore Biomedical Inc(LFCR) pay dividends? If so, how much?
Lifecore Biomedical Inc(LFCR) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers